Inflammation-dependent and independent airway remodelling in asthma
Carregando...
Citações na Scopus
51
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
ELLIOT, John G.
NOBLE, Peter B.
BAI, Tony R.
ABRAMSON, Michael J.
MCKAY, Karen O.
GREEN, Francis H. Y.
JAMES, Alan L.
Citação
RESPIROLOGY, v.23, n.12, p.1138-1145, 2018
Resumo
Background and objective The pathology of asthma is characterized by airway inflammation (granulocytic (GA) or paucigranulocytic (PGA)) and remodelling of airway structures. However, the relationship between inflammatory phenotypes and remodelling is unclear. We hypothesized that some features of airway remodelling are dependent on granulocytic airway inflammation while others are not. Methods Post-mortem airway sections from control subjects (n = 48) and cases of asthma with (n = 51) or without (n = 29) granulocytic inflammation in the inner airway wall were studied. The thickness of the airway smooth muscle (ASM) layer, basement membrane and inner and outer airway walls, the size and number of ASM cells, the volume fraction of extracellular matrix within the ASM layer, ASM shortening and luminal mucus were estimated. Airway dimensions were compared between the three subject groups. Results In cases of PGA, only the thickness of the ASM layer and basement membrane was increased compared with control subjects. In cases of GA, not only the ASM and basement membrane were increased in thickness, but there was also increased inner and outer airway wall thickness and increased narrowing of the airway lumen due to ASM shortening and mucus obstruction, compared with control subjects. Granulocytic inflammation was observed more often in cases of fatal asthma. Conclusion These findings suggest that inner and outer wall thickening coexists with inflammation, whereas thickening of the ASM layer and basement membrane may be present even in the absence of inflammation. Remodelling of the ASM layer and basement membrane may therefore be less susceptible to anti-inflammatory therapy.
Palavras-chave
airway morphology, asthma, inflammation, stereology
Referências
- Adams DC, 2016, SCI TRANSL MED, V8, P131
- AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916
- Berry M, 2007, THORAX, V62, P1043, DOI 10.1136/thx.2006.073429
- Brightling CE, 2005, CURR ALLERGY ASTHM R, V5, P130, DOI 10.1007/s11882-005-0086-9
- Burgess JK, 2004, J ALLERGY CLIN IMMUN, V113, P876, DOI 10.1016/j.jaci.2004.02.029
- Carroll N, 1996, PATHOL RES PRACT, V192, P238, DOI 10.1016/S0344-0338(96)80227-5
- Carroll N, 1997, EUR RESPIR J, V10, P292, DOI 10.1183/09031936.97.10020292
- Elliot JG, 2015, RESPIROLOGY, V20, P66, DOI 10.1111/resp.12384
- Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350
- HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603
- Herszberg B, 2006, J ALLERGY CLIN IMMUN, V118, P382, DOI 10.1016/j.jaci.2006.03.044
- James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608
- JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242
- James AL, 2002, AM J RESP CRIT CARE, V166, P1590, DOI 10.1164/rccm.2108069
- JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136
- James AL, 2013, RESPIROLOGY, V18, P1256, DOI 10.1111/resp.12147
- James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC
- Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC
- Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC
- Kramer EL, 2009, AM J RESP CELL MOL, V41, P415, DOI 10.1165/rcmb.2008-0470OC
- Kuyper LM, 2003, AM J MED, V115, P6, DOI 10.1016/S0002-9343(03)00241-9
- LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4
- Leclere M, 2012, AM J RESP CELL MOL, V47, P589, DOI 10.1165/rcmb.2011-0363OC
- Lezmi G, 2015, AM J RESP CRIT CARE, V192, P164, DOI 10.1164/rccm.201411-1958OC
- MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171
- Naveed SUN, 2017, AM J RESP CRIT CARE, V195, P1000, DOI 10.1164/rccm.201604-0822OC
- Niimi A, 2004, AM J MED, V116, P725, DOI 10.1016/j.amjmed.2003.11.026
- O'Reilly R, 2013, J ALLERGY CLIN IMMUN, V131, P1024, DOI 10.1016/j.jaci.2012.08.044
- Owens L, 2017, RESPIROLOGY, V22, P289, DOI 10.1111/resp.12901
- Pavord ID, 2007, THORAX, V62, P193, DOI 10.1136/thx.2006.065805
- Payne DNR, 2001, AM J RESP CRIT CARE, V164, P1376, DOI 10.1164/ajrccm.164.8.2101145
- PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25
- Plant PJ, 2012, AM J RESP CELL MOL, V46, P532, DOI 10.1165/rcmb.2011-0293OC
- Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC
- Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC
- Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x
- Sont JK, 1996, THORAX, V51, P496, DOI 10.1136/thx.51.5.496
- ten Brinke A, 2001, AM J RESP CRIT CARE, V164, P744, DOI 10.1164/ajrccm.164.5.2011026
- Wang KCW, 2018, CLIN SCI, V132, P327, DOI 10.1042/CS20171386
- Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309
- Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110
- WOOLCOCK AJ, 1984, AM REV RESPIR DIS, V130, P71